12/29/2020 3:20 PM | Cellular Biomedicine Group (Subject)
| Form SC 13E3/A
| |
12/29/2020 3:11 PM | Cellular Biomedicine Group (Filer)
| Form DEFM14A
| |
12/08/2020 5:52 AM | Cellular Biomedicine Group (Subject)
| Form SC 13E3/A
| |
12/08/2020 5:41 AM | Cellular Biomedicine Group (Filer)
| Form PRER14A
| |
12/04/2020 6:30 AM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/17/2020 3:14 PM | Cellular Biomedicine Group (Subject)
| Form SC 13E3/A
| |
11/17/2020 3:11 PM | Cellular Biomedicine Group (Filer)
| Form PRER14A
| |
10/26/2020 6:04 AM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/09/2020 6:16 AM | Cellular Biomedicine Group (Subject)
| Form SC 13E3
| |
10/09/2020 5:42 AM | Cellular Biomedicine Group (Filer)
| Form PREM14A
| |
|
08/28/2020 6:32 AM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2020 3:32 PM | Cellular Biomedicine Group (Issuer) NOVARTIS AG (Reporting) NOVARTIS PHARMA AG (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/12/2020 3:17 PM | Cellular Biomedicine Group (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/12/2020 10:16 AM | Cellular Biomedicine Group (Subject) Dangdai International Group Co. Ltd (Filed by)
| Form SC 13D/A
| |
08/12/2020 7:51 AM | Cellular Biomedicine Group (Subject) Liu Tony (Filed by)
| Form SC 13D/A
| |
08/12/2020 6:02 AM | Cellular Biomedicine Group (Filer)
| Form DEFA14A
| |
08/12/2020 5:56 AM | Cellular Biomedicine Group (Filer)
| Form DEFA14A
| |
08/12/2020 5:54 AM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/10/2020 3:15 PM | Cellular Biomedicine Group (Filer)
| Form NT 10-Q
| |
07/13/2020 6:32 AM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/29/2020 8:00 AM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/24/2020 3:38 PM | Cellular Biomedicine Group (Subject) HILLHOUSE CAPITAL ADVISORS, LTD. (Filed by)
| Form SC 13D/A
| |
06/24/2020 3:35 PM | Cellular Biomedicine Group (Subject) Liu Tony (Filed by)
| Form SC 13D/A
| |
06/22/2020 8:15 AM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2020 5:07 AM | Cellular Biomedicine Group (Filer)
| Form DEFR14A
| |
04/29/2020 4:19 PM | Cellular Biomedicine Group (Filer)
| Form DEFA14A
| |
04/29/2020 4:19 PM | Cellular Biomedicine Group (Filer)
| Form DEF 14A
| |
04/01/2020 8:39 AM | Cellular Biomedicine Group (Subject) Sailing Capital Overseas Investments Fund, LP (Filed by)
| Form SC 13D/A
| |
04/01/2020 8:37 AM | Cellular Biomedicine Group (Subject) TF Venture Capital Management Co., Ltd. (Filed by)
| Form SC 13D/A
| |
04/01/2020 8:33 AM | Cellular Biomedicine Group (Subject) Liu Tony (Filed by)
| Form SC 13D/A
| |
03/31/2020 9:16 AM | Cellular Biomedicine Group (Subject) Dangdai International Group Co. Ltd (Filed by)
| Form SC 13D/A
| |
02/24/2020 12:50 PM | Cellular Biomedicine Group (Subject) Dangdai International Group Co. Ltd (Filed by)
| Form SC 13D/A
| |
02/24/2020 7:00 AM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/21/2020 3:05 PM | Cellular Biomedicine Group (Subject) Liu Tony (Filed by)
| Form SC 13D/A
| |
02/13/2020 4:23 PM | Cellular Biomedicine Group (Issuer) Chan Andrew K (Reporting)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
02/13/2020 4:20 PM | Cellular Biomedicine Group (Issuer) Liu Tony (Reporting)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
02/03/2020 7:07 PM | Cellular Biomedicine Group (Issuer) Chiang Chen Hsiu-Lien (Reporting) TF Venture Capital Management Co., Ltd. (Reporting) Winsor Capital Ltd (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
02/03/2020 9:19 AM | Cellular Biomedicine Group (Subject) TF Venture Capital Management Co., Ltd. (Filed by)
| Form SC 13D
| |
01/30/2020 8:18 AM | Cellular Biomedicine Group (Subject) Liu Tony (Filed by)
| Form SC 13D/A
| |
01/30/2020 8:17 AM | Cellular Biomedicine Group (Subject) HILLHOUSE CAPITAL ADVISORS, LTD. (Filed by)
| Form SC 13D/A
| |
01/29/2020 4:00 PM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/30/2019 7:30 AM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/09/2019 5:02 AM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/20/2019 8:56 PM | Cellular Biomedicine Group (Issuer) Zhang Li Helen (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/20/2019 8:53 PM | Cellular Biomedicine Group (Issuer) Dai Chengxiang (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/20/2019 8:50 PM | Cellular Biomedicine Group (Issuer) HILLHOUSE CAPITAL ADVISORS, LTD. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/18/2019 8:56 PM | Cellular Biomedicine Group (Issuer) Mission Right Ltd (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/18/2019 10:55 AM | Cellular Biomedicine Group (Subject) Dangdal International Group Co. Ltd (Filed by)
| Form SC 13D/A
| |
11/13/2019 9:07 AM | Cellular Biomedicine Group (Subject) Liu Tony (Filed by)
| Form SC 13D
| |
11/12/2019 8:59 AM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/12/2019 7:00 AM | Cellular Biomedicine Group (Subject) HILLHOUSE CAPITAL ADVISORS, LTD. (Filed by)
| Form SC 13D
| |
11/08/2019 6:27 AM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2019 3:25 PM | Cellular Biomedicine Group (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/17/2019 3:10 PM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/15/2019 3:12 PM | Cellular Biomedicine Group (Issuer) Schafer Edward T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/15/2019 3:11 PM | Cellular Biomedicine Group (Issuer) Schafer Edward T (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/03/2019 7:30 AM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/27/2019 3:15 PM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/26/2019 4:01 PM | Cellular Biomedicine Group (Filer)
| Form CT ORDER
| |
09/12/2019 6:49 AM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/11/2019 2:24 PM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/29/2019 3:10 PM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/06/2019 3:03 PM | Cellular Biomedicine Group (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/23/2019 8:07 AM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/16/2019 11:15 PM | Cellular Biomedicine Group (Filer)
| Form EFFECT
| |
07/05/2019 3:12 PM | Cellular Biomedicine Group (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
07/03/2019 4:09 PM | Cellular Biomedicine Group (Filer)
| Form 424B3
| |
07/01/2019 4:25 PM | Cellular Biomedicine Group (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/17/2019 7:23 AM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/16/2019 4:20 PM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/30/2019 4:01 PM | Cellular Biomedicine Group (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/29/2019 8:27 AM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/25/2019 8:44 AM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/23/2019 8:24 AM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/28/2019 10:33 AM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/22/2019 8:31 PM | Cellular Biomedicine Group (Filer)
| Form 424B5
| |
03/22/2019 4:29 PM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/20/2019 3:20 PM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/20/2019 3:11 PM | Cellular Biomedicine Group (Filer)
| Form 424B5
| |
03/15/2019 4:13 PM | Cellular Biomedicine Group (Filer)
| Form DEFA14A
| |
03/15/2019 4:11 PM | Cellular Biomedicine Group (Filer)
| Form DEF 14A
| |
03/01/2019 10:05 AM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/19/2019 4:01 PM | Cellular Biomedicine Group (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/14/2019 8:53 PM | Cellular Biomedicine Group (Issuer) Chan Andrew K (Reporting)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
02/14/2019 8:50 PM | Cellular Biomedicine Group (Issuer) Liu Tony (Reporting)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
02/14/2019 8:48 PM | Cellular Biomedicine Group (Issuer) Yao Yihong (Reporting)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
01/25/2019 3:45 PM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/17/2019 5:30 AM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/09/2019 7:00 AM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/28/2018 3:11 PM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/10/2018 1:10 PM | Cellular Biomedicine Group (Subject) Dangdal International Group Co. Ltd (Filed by)
| Form SC 13D/A
| |
11/06/2018 5:26 AM | Cellular Biomedicine Group (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/29/2018 7:07 AM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/23/2018 8:16 AM | Cellular Biomedicine Group (Filer)
| Form 424B3
| |
10/22/2018 11:15 PM | Cellular Biomedicine Group (Filer)
| Form EFFECT
| |
10/18/2018 3:13 PM | Cellular Biomedicine Group (Filer)
| Form CT ORDER
| |
10/18/2018 3:06 PM | Cellular Biomedicine Group (Filer)
| Form CT ORDER
| |
10/10/2018 6:11 PM | Cellular Biomedicine Group (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
10/10/2018 7:30 AM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/09/2018 4:27 PM | Cellular Biomedicine Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |